Editorial: Critical complications in pediatric oncology and hematopoietic cell transplant – how far we have come and how much further we must go

Asya Agulnik; Kris M. Mahadeo; Marie E. Steiner; Jennifer Ann McArthur

doi:10.3389/fonc.2023.1148321

Editorial: Critical complications in pediatric oncology and hematopoietic cell transplant – how far we have come and how much further we must go

Asya Agulnik, Kris M. Mahadeo, Marie E. Steiner, Jennifer Ann McArthur

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Article number	1148321
Journal	Frontiers in Oncology
Volume	13
DOIs	https://doi.org/10.3389/fonc.2023.1148321
State	Published - 2023
Externally published	Yes

Bibliographical note

Funding Information:
KM declares investigator funding from Jazz and Atara; MS declares department of defense contract funding for cold platelet study, NIH honorarium for PumpKiN DSMB, Medtronic contract for hemostasis teaching, Octapharma honorarium for clinical trial design consultation.

Keywords

CAR (chimeric antigen receptor) T cells
hematopoietic cell transplant
pediatric cancer
pediatric critical care
pediatric oncology and hematology

PubMed: MeSH publication types

Editorial

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.3389/fonc.2023.1148321

OpenUrl availability

Full text

Cite this

@article{5b270e2f11304109b1ce8603601c2ad1,

title = "Editorial: Critical complications in pediatric oncology and hematopoietic cell transplant – how far we have come and how much further we must go",

keywords = "CAR (chimeric antigen receptor) T cells, hematopoietic cell transplant, pediatric cancer, pediatric critical care, pediatric oncology and hematology",

author = "Asya Agulnik and Mahadeo, {Kris M.} and Steiner, {Marie E.} and McArthur, {Jennifer Ann}",

note = "Funding Information: KM declares investigator funding from Jazz and Atara; MS declares department of defense contract funding for cold platelet study, NIH honorarium for PumpKiN DSMB, Medtronic contract for hemostasis teaching, Octapharma honorarium for clinical trial design consultation. ",

year = "2023",

doi = "10.3389/fonc.2023.1148321",

language = "English (US)",

volume = "13",

journal = "Frontiers in Oncology",

issn = "2234-943X",

publisher = "Frontiers Media S. A.",

}

TY - JOUR

T1 - Editorial

T2 - Critical complications in pediatric oncology and hematopoietic cell transplant – how far we have come and how much further we must go

AU - Agulnik, Asya

AU - Mahadeo, Kris M.

AU - Steiner, Marie E.

AU - McArthur, Jennifer Ann

N1 - Funding Information: KM declares investigator funding from Jazz and Atara; MS declares department of defense contract funding for cold platelet study, NIH honorarium for PumpKiN DSMB, Medtronic contract for hemostasis teaching, Octapharma honorarium for clinical trial design consultation.

PY - 2023

Y1 - 2023

KW - CAR (chimeric antigen receptor) T cells

KW - hematopoietic cell transplant

KW - pediatric cancer

KW - pediatric critical care

KW - pediatric oncology and hematology

UR - http://www.scopus.com/inward/record.url?scp=85149665809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85149665809&partnerID=8YFLogxK

U2 - 10.3389/fonc.2023.1148321

DO - 10.3389/fonc.2023.1148321

M3 - Editorial

C2 - 36910613

AN - SCOPUS:85149665809

SN - 2234-943X

VL - 13

JO - Frontiers in Oncology

JF - Frontiers in Oncology

M1 - 1148321

ER -

Editorial: Critical complications in pediatric oncology and hematopoietic cell transplant – how far we have come and how much further we must go

Bibliographical note

Keywords

PubMed: MeSH publication types

UN SDGs

Access

OpenUrl availability

Other files and links

Cite this